Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |